The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Primary results of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma (HNSCC) with double checkpoint blockade and radiotherapy dependent on intratumoral CD8+ T-cell infiltration.
 
Markus Hecht
Honoraria - Bristol-Myers Squibb; Merck Serono; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD
Research Funding - AstraZeneca (Inst); Merck Serono (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Markus Eckstein
Employment - Diaceutics
Honoraria - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Cepheid; Diaceutics; Genomic Health; Janssen
Speakers' Bureau - Astellas Pharma; AstraZeneca; Cepheid; Diaceutics; Genomic Health; Janssen; MSD; Roche
Research Funding - AstraZeneca; Cepheid; Janssen; Stratifyer GmbH
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Cepheid; Diaceutics; Genomic Health; Janssen; MSD; Roche
 
Sandra Rutzner
No Relationships to Disclose
 
Jens von der Grün
No Relationships to Disclose
 
Thomas Illmer
No Relationships to Disclose
 
Gunther Klautke
Consulting or Advisory Role - AstraZeneca; Merck; Roche
Speakers' Bureau - Genzyme; Roche; Sanofi
 
Simon Laban
Honoraria - Bristol-Myers Squibb (Inst); Merck Serono (Inst); MSD (Inst)
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Genzyme (Inst); MSD (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Merck Serono (Inst)
 
Matthias G. Hautmann
Stock and Other Ownership Interests - Roche; Sanofi; Varian Medical Systems
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene; Merck; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
 
Thomas Brunner
Travel, Accommodations, Expenses - Prime Oncology
 
Balint Tamaskovics
Honoraria - Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Axel Hinke
Honoraria - Ipsen; Roche Pharma AG
 
Benjamin Frey
No Relationships to Disclose
 
Sabine Semrau
Stock and Other Ownership Interests - Abbott; BioNTech; crispr therapeutics; Gerresheimer; Novartis; Siemens; Stryker; Varian Medical Systems
Honoraria - Ortho; Pharmamar
Consulting or Advisory Role - Ortho (I)
Speakers' Bureau - Ortho; PharmaMar
Travel, Accommodations, Expenses - Orhto; PharmaMar
 
Arndt Hartmann
Honoraria - Abbvie; AstraZeneca; BMS; Boehringer Ingelheim; Ipsen; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - 3DHISTECH; AstraZeneca; Bristol-Myers Squibb; Cepheid; Diaceutics; Illumina; Ipsen; Janssen-Cilag; MSD; NanoString Technologies; Qiagen; Roche
Research Funding - AstraZeneca; BioNTech; Cepheid; Janssen-Cilag; NanoString Technologies; Roche
Expert Testimony - NanoString Technologies
 
Panagiotis Balermpas
Research Funding - ViewRay (Inst)
 
Wilfried Budach
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; MSD; Pfizer; Promedicis
 
Udo S Gaipl
Consulting or Advisory Role - Sennewald GmbH
Travel, Accommodations, Expenses - Sennewald GmbH
 
Heinrich Iro
No Relationships to Disclose
 
Antoniu-Oreste Gostian
No Relationships to Disclose
 
Rainer Fietkau
Honoraria - AstraZeneca; Merck Serono; Merck Serono; Merck Sharp & Dohme; Novocure; Sennewald GmbH
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck; MSD Oncology; Novocure
Speakers' Bureau - AstraZeneca; MSD; Novocure; Sennewald GmbH
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Debios (Inst); Merck (Inst); MSD Oncology (Inst); Novocure (Inst); Siemens Healthineers (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Merck; MSD Oncology; Novocure; Sennewald GmbH